Skip to main content

Call for papers - Tumor immune contexture in cancer progression and treatment

Genome Medicine is calling for submissions to a new Collection on Tumor immune contexture in cancer progression and treatment guest edited by Noel De Miranda. Deadline 15 June 2024

Call for papers - Advances in healthy aging and age-related diseases

Genome Medicine is calling for submissions to a new Collection on advances in healthy aging and
age-related diseases, guest edited by Joris Deleen and Henne Holstege. Deadline 26 April 2024.

Call for papers - Genome instability in cancer: from mechanisms to the clinic

Genome Medicine is calling for submissions to our Collection focusing on genome instability in cancer, guest edited by Christopher Lord and Timothy Yap. Deadline 31 March 2024. 

Call for papers - Cardiovascular disease: omics approaches and clinical applications

Submission deadline has been extended to 1 December 2023 for our Cardiovascular disease Collection guest edited by James Ware and Connie Bezzina.

Reviews, Research Highlights and Commentaries

Read authoritative Reviews, Opinions and other content commissioned by the Genome Medicine Editors from leading researchers:


Research Highlights

Commentaries (including Editorials, Comments, Opinions, Q&As and Meeting reports)


  1. Authors: Gaby Schobers, Ronny Derks, Amber den Ouden, Hilde Swinkels, Jeroen van Reeuwijk, Ermanno Bosgoed, Dorien Lugtenberg, Su Ming Sun, Jordi Corominas Galbany, Marjan Weiss, Marinus J. Blok, Richelle A. C. M. Olde Keizer, Tom Hofste, Debby Hellebrekers, Nicole de Leeuw, Alexander Stegmann…

Focus: The human microbiome in health and disease

Read the latest Research and and Reviews on the human microbiome in health and disease:

Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides
Langdon, A., Schwartz, D.J., Bulow, C. et al. Genome Med 13, 28 (2021)

Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer
Hayase, E., Jenq, R.R. Genome Med 13, 107 (2021)

Strain-level epidemiology of microbial communities and the human microbiome
Yan, Y., Nguyen, L.H., Franzosa, E.A. et al. Genome Med 12, 71 (2020).

Bacteroides vulgatus and Bacteroides dorei predict immune-related adverse events in immune checkpoint blockade treatment of metastatic melanoma
Usyk, M., Pandey, A., Hayes, R.B. et al. Genome Med 13, 160 (2021).

Aims and scope

Genome Medicine publishes important advances of broad interest in the application of genetics, genomics and multi-omics to understand, diagnose and treat disease. The Journal aims to bridge the basic science and clinical research communities in areas that include, but are not limited to: cancer genomics, immuno-oncology, immunogenomics, infectious disease, microbiome, cardiology, neurogenomics, systems medicine, clinical genomics, gene therapies, precision medicine, and clinical trials. The Journal content includes original research, method, software, database and guideline articles as well as reviews, opinions and commentaries. 

Article collections

Special issue
The impact of genomics on precision public health
Guest editors: Muin Khoury and Kathryn Holt

Special issue
Translating the microbiome in health and disease
Guest editor: Ramnik Xavier

Special issue
Clinical interpretation of genome variation
Guest editors: Heidi Rehm and Douglas Fowler

A decade of Genome Medicine

Special issue
Tumor immune microenvironment and immunotherapy
Guest editors: Zlatko Trajanoski and Noel de Miranda

Special issue
From genome integrity to cancer
Guest editor: Serena Nik-Zainal

See all article collections

Annual Journal Metrics

  • 2022 Citation Impact
    12.3 - 2-year Impact Factor
    13.8 - 5-year Impact Factor
    2.422 - SNIP (Source Normalized Impact per Paper)
    4.851 - SJR (SCImago Journal Rank)

    2022 Speed
    9 days submission to first editorial decision for all manuscripts (Median)
    212 days submission to accept (Median)

    2022 Usage 
    14,220 Altmetric mentions 

  • Peer Review Taxonomy

    This journal is participating in a pilot of NISO/STM's Working Group on Peer Review Taxonomy, to identify and standardize definitions and terminology in peer review practices in order to make the peer review process for articles and journals more transparent. Further information on the pilot is available here

    The following summary describes the peer review process for this journal:

    • Identity transparency: Single anonymized
    • Reviewer interacts with: Editor
    • Review information published: None

    We welcome your feedback on this Peer Review Taxonomy Pilot. Please can you take the time to complete this short survey.